List of Chapters/Sections(Table Of Content)
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Pediatric Drugs and Vaccines Revenue
1.4 Market Analysis by Type
1.4.1 Global Pediatric Drugs and Vaccines Market Size Growth Rate by Type: 2021 VS 2027
1.4.2 Diphtheria
1.4.3 Influenza
1.4.4 Hepatitis
1.4.5 Pneumococcal Diseases
1.4.6 Meningococcal Diseases
1.4.7 Mumps
1.5 Market by Application
1.5.1 Global Pediatric Drugs and Vaccines Market Share by Application: 2022-2027
1.5.2 Newborn
1.5.3 Infant
1.5.4 Child
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Pediatric Drugs and Vaccines Market
1.8.1 Global Pediatric Drugs and Vaccines Market Status and Outlook (2016-2027)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Pediatric Drugs and Vaccines Production Capacity Market Share by Manufacturers (2016-2021)
2.2 Global Pediatric Drugs and Vaccines Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Pediatric Drugs and Vaccines Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Pediatric Drugs and Vaccines Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Pediatric Drugs and Vaccines Sales Volume Market Share by Region (2016-2021)
3.2 Global Pediatric Drugs and Vaccines Sales Revenue Market Share by Region (2016-2021)
3.3 North America Pediatric Drugs and Vaccines Sales Volume
3.3.1 North America Pediatric Drugs and Vaccines Sales Volume Growth Rate (2016-2021)
3.3.2 North America Pediatric Drugs and Vaccines Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.4 East Asia Pediatric Drugs and Vaccines Sales Volume
3.4.1 East Asia Pediatric Drugs and Vaccines Sales Volume Growth Rate (2016-2021)
3.4.2 East Asia Pediatric Drugs and Vaccines Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.5 Europe Pediatric Drugs and Vaccines Sales Volume (2016-2021)
3.5.1 Europe Pediatric Drugs and Vaccines Sales Volume Growth Rate (2016-2021)
3.5.2 Europe Pediatric Drugs and Vaccines Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.6 South Asia Pediatric Drugs and Vaccines Sales Volume (2016-2021)
3.6.1 South Asia Pediatric Drugs and Vaccines Sales Volume Growth Rate (2016-2021)
3.6.2 South Asia Pediatric Drugs and Vaccines Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.7 Southeast Asia Pediatric Drugs and Vaccines Sales Volume (2016-2021)
3.7.1 Southeast Asia Pediatric Drugs and Vaccines Sales Volume Growth Rate (2016-2021)
3.7.2 Southeast Asia Pediatric Drugs and Vaccines Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.8 Middle East Pediatric Drugs and Vaccines Sales Volume (2016-2021)
3.8.1 Middle East Pediatric Drugs and Vaccines Sales Volume Growth Rate (2016-2021)
3.8.2 Middle East Pediatric Drugs and Vaccines Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.9 Africa Pediatric Drugs and Vaccines Sales Volume (2016-2021)
3.9.1 Africa Pediatric Drugs and Vaccines Sales Volume Growth Rate (2016-2021)
3.9.2 Africa Pediatric Drugs and Vaccines Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.10 Oceania Pediatric Drugs and Vaccines Sales Volume (2016-2021)
3.10.1 Oceania Pediatric Drugs and Vaccines Sales Volume Growth Rate (2016-2021)
3.10.2 Oceania Pediatric Drugs and Vaccines Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.11 South America Pediatric Drugs and Vaccines Sales Volume (2016-2021)
3.11.1 South America Pediatric Drugs and Vaccines Sales Volume Growth Rate (2016-2021)
3.11.2 South America Pediatric Drugs and Vaccines Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.12 Rest of the World Pediatric Drugs and Vaccines Sales Volume (2016-2021)
3.12.1 Rest of the World Pediatric Drugs and Vaccines Sales Volume Growth Rate (2016-2021)
3.12.2 Rest of the World Pediatric Drugs and Vaccines Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
4 North America
4.1 North America Pediatric Drugs and Vaccines Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Pediatric Drugs and Vaccines Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Pediatric Drugs and Vaccines Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Pediatric Drugs and Vaccines Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Pediatric Drugs and Vaccines Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Pediatric Drugs and Vaccines Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Pediatric Drugs and Vaccines Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Pediatric Drugs and Vaccines Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Pediatric Drugs and Vaccines Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Pediatric Drugs and Vaccines Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Pediatric Drugs and Vaccines Sales Volume Market Share by Type (2016-2021)
14.2 Global Pediatric Drugs and Vaccines Sales Revenue Market Share by Type (2016-2021)
14.3 Global Pediatric Drugs and Vaccines Sales Price by Type (2016-2021)
15 Consumption Analysis by Application
15.1 Global Pediatric Drugs and Vaccines Consumption Volume by Application (2016-2021)
15.2 Global Pediatric Drugs and Vaccines Consumption Value by Application (2016-2021)
16 Company Profiles and Key Figures in Pediatric Drugs and Vaccines Business
16.1 Merck & Co., Inc. (USA)
16.1.1 Merck & Co., Inc. (USA) Company Profile
16.1.2 Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Product Specification
16.1.3 Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.2 Abbott Laboratories (USA)
16.2.1 Abbott Laboratories (USA) Company Profile
16.2.2 Abbott Laboratories (USA) Pediatric Drugs and Vaccines Product Specification
16.2.3 Abbott Laboratories (USA) Pediatric Drugs and Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.3 Amgen, Inc. (USA)
16.3.1 Amgen, Inc. (USA) Company Profile
16.3.2 Amgen, Inc. (USA) Pediatric Drugs and Vaccines Product Specification
16.3.3 Amgen, Inc. (USA) Pediatric Drugs and Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.4 Eli Lilly and Company (USA)
16.4.1 Eli Lilly and Company (USA) Company Profile
16.4.2 Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Product Specification
16.4.3 Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.5 F. Hoffmann-La Roche Ltd (Switzerland)
16.5.1 F. Hoffmann-La Roche Ltd (Switzerland) Company Profile
16.5.2 F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Product Specification
16.5.3 F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.6 Genentech, Inc. (USA)
16.6.1 Genentech, Inc. (USA) Company Profile
16.6.2 Genentech, Inc. (USA) Pediatric Drugs and Vaccines Product Specification
16.6.3 Genentech, Inc. (USA) Pediatric Drugs and Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.7 GlaxoSmithKline plc. (UK)
16.7.1 GlaxoSmithKline plc. (UK) Company Profile
16.7.2 GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Product Specification
16.7.3 GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.8 Janssen Biologics B.V. (USA)
16.8.1 Janssen Biologics B.V. (USA) Company Profile
16.8.2 Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Product Specification
16.8.3 Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.9 Actelion Pharmaceuticals
16.9.1 Actelion Pharmaceuticals Company Profile
16.9.2 Actelion Pharmaceuticals Pediatric Drugs and Vaccines Product Specification
16.9.3 Actelion Pharmaceuticals Pediatric Drugs and Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.10 AstraZeneca Plc. (UK)
16.10.1 AstraZeneca Plc. (UK) Company Profile
16.10.2 AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Product Specification
16.10.3 AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.11 Boehringer Ingelheim GmbH (Germany)
16.11.1 Boehringer Ingelheim GmbH (Germany) Company Profile
16.11.2 Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Product Specification
16.11.3 Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.12 Bristol-Myers Squibb Company (USA)
16.12.1 Bristol-Myers Squibb Company (USA) Company Profile
16.12.2 Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Product Specification
16.12.3 Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.13 Allergan, Inc. (USA)
16.13.1 Allergan, Inc. (USA) Company Profile
16.13.2 Allergan, Inc. (USA) Pediatric Drugs and Vaccines Product Specification
16.13.3 Allergan, Inc. (USA) Pediatric Drugs and Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.14 Novartis AG (Switzerland)
16.14.1 Novartis AG (Switzerland) Company Profile
16.14.2 Novartis AG (Switzerland) Pediatric Drugs and Vaccines Product Specification
16.14.3 Novartis AG (Switzerland) Pediatric Drugs and Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.15 Novo Nordisk A/S (Denmark)
16.15.1 Novo Nordisk A/S (Denmark) Company Profile
16.15.2 Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Product Specification
16.15.3 Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.16 Pfizer, Inc. (USA)
16.16.1 Pfizer, Inc. (USA) Company Profile
16.16.2 Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Product Specification
16.16.3 Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.17 Sanofi S.A (France)
16.17.1 Sanofi S.A (France) Company Profile
16.17.2 Sanofi S.A (France) Pediatric Drugs and Vaccines Product Specification
16.17.3 Sanofi S.A (France) Pediatric Drugs and Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.18 Shionogi Inc. (USA)
16.18.1 Shionogi Inc. (USA) Company Profile
16.18.2 Shionogi Inc. (USA) Pediatric Drugs and Vaccines Product Specification
16.18.3 Shionogi Inc. (USA) Pediatric Drugs and Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.19 Takeda
16.19.1 Takeda Company Profile
16.19.2 Takeda Pediatric Drugs and Vaccines Product Specification
16.19.3 Takeda Pediatric Drugs and Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
17 Pediatric Drugs and Vaccines Manufacturing Cost Analysis
17.1 Pediatric Drugs and Vaccines Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Pediatric Drugs and Vaccines
17.4 Pediatric Drugs and Vaccines Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Pediatric Drugs and Vaccines Distributors List
18.3 Pediatric Drugs and Vaccines Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Pediatric Drugs and Vaccines (2022-2027)
20.2 Global Forecasted Revenue of Pediatric Drugs and Vaccines (2022-2027)
20.3 Global Forecasted Price of Pediatric Drugs and Vaccines (2016-2027)
20.4 Global Forecasted Production of Pediatric Drugs and Vaccines by Region (2022-2027)
20.4.1 North America Pediatric Drugs and Vaccines Production, Revenue Forecast (2022-2027)
20.4.2 East Asia Pediatric Drugs and Vaccines Production, Revenue Forecast (2022-2027)
20.4.3 Europe Pediatric Drugs and Vaccines Production, Revenue Forecast (2022-2027)
20.4.4 South Asia Pediatric Drugs and Vaccines Production, Revenue Forecast (2022-2027)
20.4.5 Southeast Asia Pediatric Drugs and Vaccines Production, Revenue Forecast (2022-2027)
20.4.6 Middle East Pediatric Drugs and Vaccines Production, Revenue Forecast (2022-2027)
20.4.7 Africa Pediatric Drugs and Vaccines Production, Revenue Forecast (2022-2027)
20.4.8 Oceania Pediatric Drugs and Vaccines Production, Revenue Forecast (2022-2027)
20.4.9 South America Pediatric Drugs and Vaccines Production, Revenue Forecast (2022-2027)
20.4.10 Rest of the World Pediatric Drugs and Vaccines Production, Revenue Forecast (2022-2027)
20.5 Forecast by Type and by Application (2022-2027)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027)
20.5.2 Global Forecasted Consumption of Pediatric Drugs and Vaccines by Application (2022-2027)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Pediatric Drugs and Vaccines by Country
21.2 East Asia Market Forecasted Consumption of Pediatric Drugs and Vaccines by Country
21.3 Europe Market Forecasted Consumption of Pediatric Drugs and Vaccines by Countriy
21.4 South Asia Forecasted Consumption of Pediatric Drugs and Vaccines by Country
21.5 Southeast Asia Forecasted Consumption of Pediatric Drugs and Vaccines by Country
21.6 Middle East Forecasted Consumption of Pediatric Drugs and Vaccines by Country
21.7 Africa Forecasted Consumption of Pediatric Drugs and Vaccines by Country
21.8 Oceania Forecasted Consumption of Pediatric Drugs and Vaccines by Country
21.9 South America Forecasted Consumption of Pediatric Drugs and Vaccines by Country
21.10 Rest of the world Forecasted Consumption of Pediatric Drugs and Vaccines by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer
